Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years - Wilding, J P; Woo, V; Rohwedder, K; Sugg, J; Parikh, SDapagliflozin 006 Study Group (Diabetes Obes Metab., 2009)
2013 Aug 1. [Epub ahead of print]